 |
 The Team
DAVID YEE, Ph.D.
Research Analyst
After obtaining his Ph.D. degree in organic chemistry at Cornell University, Dr. Yee conducted enzymological research as a Stipendiat at the Max Planck Institute for Experimental Chemistry in Göttingen, Germany and as a research associate at Harvard University. He was Director of Research and Development for a biopharmaceutical company before joining the Genesis Group as Senior Technology Analyst. In the latter position he provided strategic analysis and forecasting of technology and market trends within the pharmaceutical and biotechnology sectors, projected future technology trends for various disease states based on market survey analysis, and assessed the competitive impact of technologies and programs in development against currently marketed agents. In 2003 the Genesis Group was acquired by Wolters Kluwer, where Dr. Yee continued to use his scientific background in providing customized business intelligence to the pharmaceutical industry.
|
|
